CONFERENCE ANNOUNCEMENT AND CALL FOR SPEAKER PROPOSALS

Cambridge Healthtech Institute's Third Annual

difficult to express proteins

Effective Solutions for Improving the Expression of "Finicky" Proteins

Part of the Third Annual PEGS: Protein Engineering Summit


May 14-15, 2007 - Intercontinental Hotel - Boston, MA

GPCRs, kinases, ion channels, blood plasma proteins, vaccines, and antibodies are just some of the classes of proteins which have proven very difficult to express in quantities large enough to feed the pipeline of therapeutic proteins. This conference will present strategies for improving the expression of these ?finicky? proteins, as well as providing researchers with opportunities to network with groups which are successfully overcoming these challenges.

Topics may include, but are not limited to:

Automation of expression and purification
Novel expression systems or novel applications of existing systems
Overcoming folding problems
Improving yield
Managing glycosylation
Post translational processing
Overcoming insolubility issues
Finding the right expression system
Case studies of success stories or failures

Researchers are encouraged to submit a title and short 3-5 sentence summary of your data, suitable for use in the program brochure should your abstract be selected for oral presentation. Please include full contact information for the presenter.

Submit a Proposal for Consideration.

Register for PEGS

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program.


For more information, please contact:
Elizabeth Lamb
Senior Conference Director
Cambridge Healthtech Institute
Fax: 207-493-7874
E-mail: elamb@healthtech.com

For exhibits and sponsorship information, please contact:
Carol Dinerstein
Cambridge Healthtech Institute
250 First Avenue, Suite 300
Needham, MA 02494
Tel: 781-972-5471
email: dinerstein@healthtech.com

Cambridge Healthtech Institute, 250 First Avenue, Suite 300, Needham, MA 02494

If the above information is not of interest to you, please disregard and we apologize for any inconvenience
this may have caused. To be removed from further emails, click here or go to www.chiresource.com/rmv



.asp